---
title: Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors
description: "https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00045
Read the publication. Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors. Contact Evotec to learn more!"
image: https://news.cyprotex.com/hubfs/Sciencepool/Sciencepool%20images/Shutterstock%20images/shutterstock_1470847370-lungs-blue-01-science-pool.jpg
---

[![Cyprotex | The Leading ADME-Tox Specialist](https://news.cyprotex.com/hs-fs/hubfs/cyprotex%20logo.png?width=224&height=62&name=cyprotex%20logo.png "Cyprotex | The Leading ADME-Tox Specialist")](https://www.cyprotex.com/)

# Science Pool

# Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors

Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 4, 2021 9:46:18 PM

 Tags: [Medicinal Chemistry](https://news.cyprotex.com/sciencepool/tag/medicinal-chemistry), [Respiratory](https://news.cyprotex.com/sciencepool/tag/respiratory), [Articles & Whitepapers](https://news.cyprotex.com/sciencepool/tag/articles-whitepapers), [Immunology & Inflammation](https://news.cyprotex.com/sciencepool/tag/immunology-inflammation)